LDL-IN-3

• Description :

  LDL-IN-3 is an anti-atherosclerotic compound extracted from patent WO/2005/039596A1, example C25 and patent US 6133467, example 3.

• CAS Number :

  [180908-67-2]

• UNSPSC :

  12352005

• Target :

  LDLR

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Metabolism-sugar/lipid metabolism

• Field of Research :

  Metabolic Disease; Cardiovascular Disease

• Assay Protocol :

  https://www.medchemexpress.com/2,6-Bis_1,1-dimethylethyl_-4-[[_4-methoxyphenyl_dimethylsilyl]methoxy]phenol.html

• Solubility :

  10 mM in DMSO

• Smiles :

  OC1=C(C(C)(C)C)C=C(OC[Si](C)(C2=CC=C(OC)C=C2)C)C=C1C(C)(C)C

• Molecular Formula :

  C24H36O3Si

• Molecular Weight :

  400.63

• References & Citations :

  [1]WO/2005/039596A1|[2]US 6133467

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported